Tailored Therapy for Helicobacter Pylori in Children
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the eradication rates，safety and compliance of tailored
therapy to those of standard triple therapy in children with H. pylori infection. The primary
purpose is to compare the eradication rates of children with H. pylori infection treated with
tailored therapy to those treated with standard triple therapy. The secondary purpose is to
evaluate the safety, compliance and factors that might affect eradication rates.